Polaryx Therapeutics Inc
PLYX
13 hedge funds and large institutions have $5.83M invested in Polaryx Therapeutics Inc in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.16% less ownership
Funds ownership: 4.79% → 4.63% (-0.16%)
7% less funds holding
Funds holding: 14 → 13 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
66% less capital invested
Capital invested by funds: $17.1M → $5.83M (-$11.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$322K |
| 2 |
Jane Street
New York
|
+$123K |
| 3 |
AF
Allworth Financial
Folsom,
California
|
+$30.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.79K |
| 5 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$2.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$964K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$196K |
| 3 |
Goldman Sachs
New York
|
-$102K |
| 4 |
Squarepoint
New York
|
-$93.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$47.9K |
PLYX Hedge Fund Activity: Q2 2026 in Review
13 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in Polaryx Therapeutics Inc (PLYX) for Q2 2026, worth a combined $5.83M — down 66% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PLYX and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $322K. The largest seller was Millennium Management, exiting entirely with an estimated $964K sold.
- 13 institutional investors held Polaryx Therapeutics Inc (PLYX) as of Q2 2026, down from 14 in Q1 2026.
- Funds reported $5.83M of Polaryx Therapeutics Inc stock for Q2 2026, down 66% quarter-over-quarter.
- 4 funds opened new Polaryx Therapeutics Inc positions in Q2 2026 and 5 closed out, a net change of -1 holder.
- The largest Polaryx Therapeutics Inc buyer in Q2 2026 was HRT Financial, an estimated $322K added.
- The largest Polaryx Therapeutics Inc seller in Q2 2026 was Millennium Management, an estimated $964K sold.
Based on aggregated 13F filings for Q2 2026.